Guardant Health Biopsy Results

Listing Websites about Guardant Health Biopsy Results

Filter Type:

Tests for Patients with Early and Advanced Stage Cancer

(2 days ago) WEBOur Guardant360 Response test is the first tissue-free biopsy that enables doctors to view molecular response, or changes in circulating tumor DNA (ctDNA) levels, to get an early indication of patient response to immunotherapy or targeted therapy for advanced stage …

https://guardanthealth.com/products/tests-for-patients-with-early-and-advanced-stage-cancer/

Category:  Health Show Health

Guardant360®: Comprehensive Liquid Biopsy Test - Guardant …

(3 days ago) WEBGuardant360®: Comprehensive Liquid Biopsy Test. Information. For Guardant360 CDx: Guardant360® liquid biopsy test assesses an expanded panel of biomarkers to inform …

https://www.guardantcomplete.com/products/guardant360

Category:  Health Show Health

Patient Guide for Genomic Testing With Liquid Biopsy

(9 days ago) WEBGuardant Access. To enroll in the Guardant Access program, sign the test order form provided by your doctor. If you are unsure if you signed the form, contact Guardant …

https://demo-staging.guardant360cdx.com/wp-content/uploads/patient-brochure.pdf

Category:  Health Show Health

Guardant Complete: Monitor Cancer Status & Treatment Results

(2 days ago) WEBReach us via phone at 855.698.8887 or via email at [email protected]. Guardant Complete liquid & tissue tests enable your doctor to monitor cancer …

https://www.guardantcomplete.com/patients/

Category:  Cancer Show Health

Patient Guide – Guardant Health

(Just Now) WEBGuardant360 ® examines 70+ clinically-relevant genes to identify genomic alterations within your cancer’s DNA while avoiding the complications and delays of a tissue biopsy. Some of these genomic alterations may …

https://guardanthealth.eu/patient-guide/

Category:  Cancer Show Health

Guardant Health - Wikipedia

(5 days ago) WEBGuardant Health said the test would be the "first and only comprehensive biopsy-free cancer test available". In 2016, the company announced clinical trial results …

https://en.wikipedia.org/wiki/Guardant_Health

Category:  Cancer Show Health

Guardant Complete: Precision Oncology Liquid & Tissue Tests

(3 days ago) WEBGuardant Complete is a portfolio of revolutionary liquid and tissue precision oncology tests, all with the convenience of a single testing company. 1,2. Find the tests you need. …

https://www.guardantcomplete.com/

Category:  Health Show Health

Guardant Health – Guardant360 Liquid Biopsy Assay Guardant …

(9 days ago) WEBResults can be unpredictable, may take a month or longer, and can be incomplete. Insufficient availability of tissue. Exhausted by diagnostic needs and PD-L1 testing. …

http://www.guardanthealth.eu/

Category:  Health Show Health

Guardant Blood Test Works as Well as Biopsy in Lung Cancer Care

(4 days ago) WEBListen. 1:31. This article is for subscribers only. Time is of the essence for lung cancer patients, and new results from a study of Guardant Health’s blood test …

https://www.bloomberg.com/news/articles/2019-02-27/guardant-blood-test-works-as-well-as-biopsy-in-lung-cancer-care

Category:  Cancer Show Health

Study Shows Guardant Reveal™ Blood-Only Liquid Biopsy Test …

(4 days ago) WEBGuardant Health has commercially launched liquid biopsy-based Guardant360 ®, Guardant360 CDx, and GuardantOMNI ® tests for advanced stage …

https://www.businesswire.com/news/home/20210430005142/en/Study-Shows-Guardant-Reveal%E2%84%A2-Blood-Only-Liquid-Biopsy-Test-Predicts-Risk-for-Colorectal-Cancer-Recurrence-with-Industry-Leading-Sensitivity

Category:  Health Show Health

Guardant preps for FDA review of colorectal cancer blood test

(9 days ago) WEBGuardant Health has its sights set on redefining how people get checked for colorectal cancer, and its blood test for catching stray tumor DNA soon has a date with …

https://www.fiercebiotech.com/medtech/guardant-health-preps-fda-advisory-panel-review-its-blood-based-colorectal-cancer-screening

Category:  Cancer Show Health

Guardant360 Response™: Liquid Biopsy for - Guardant Complete

(2 days ago) WEBGuardant360 CDx is not approved by the US FDA to assess treatment response or long-term survival. *Turnaround time of under 2 weeks is from sample receipt to results. † …

https://www.guardantcomplete.com/products/guardant360-response

Category:  Health Show Health

Guardant360® CDx liquid biopsy is helping to bring the …

(4 days ago) WEBGuardant Health is leading the way for liquid biopsy to help patients across the cancer care continuum In 2014, we introduced the Guardant360 test for advanced cancer …

https://purtal.guardanthealth.com/wp-content/uploads/Guardant360_CDx_Backgrounder_Document.pdf

Category:  Cancer Show Health

Guardant Health Launches Guardant Reveal™ Liquid Biopsy Test

(9 days ago) WEBResults are obtained from a simple blood draw and returned in as little as 7 days without the need for a tissue biopsy. benefits and advantages of Guardant …

https://www.nasdaq.com/press-release/guardant-health-launches-guardant-revealtm-liquid-biopsy-test-for-residual-disease

Category:  Health Show Health

Guardant Health Reports First Quarter 2024 Financial Results and

(3 days ago) WEBPALO ALTO, Calif., May 09, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended …

https://finance.yahoo.com/news/guardant-health-reports-first-quarter-200500610.html

Category:  Health Show Health

Guardant Health to present real-world data supporting …

(5 days ago) WEBThe data served as the basis for Guardant Health’s submission of a premarket approval (PMA) application to the FDA, and the full study results have since …

https://www.businesswire.com/news/home/20240516838593/en/Guardant-Health-to-present-real-world-data-supporting-performance-of-Shield%E2%84%A2-blood-test-for-colorectal-cancer-screening-at-2024-Digestive-Disease-Week

Category:  Health Show Health

Guardant Health, Inc. (NASDAQ:GH) Q1 2024 Earnings Call …

(6 days ago) WEBEarlier today, Guardant Health released financial results for the quarter ended March 31, 2024. Guardant is a liquid biopsy leader for therapy selection with a robust pipeline …

https://www.msn.com/en-us/money/companies/guardant-health-inc-nasdaq-gh-q1-2024-earnings-call-transcript/ar-BB1mjnP3

Category:  Health Show Health

microRNA-Based Liquid Biopsy Detects Early Pancreatic Cancer

(Just Now) WEBScientists have developed a blood test that can accurately detect early-stage pancreatic cancer, according to results from a large study. The test is a liquid …

https://www.cancer.gov/news-events/cancer-currents-blog/2024/liquid-biopsy-detects-pancreatic-cancer

Category:  Cancer Show Health

Guardant Health, Inc. (GH) Q1 2024 Earnings Call Transcript

(6 days ago) WEBEarlier today, Guardant Health released financial results for the quarter ended March 31, 2024. Guardant is a liquid biopsy leader for therapy selection with …

https://seekingalpha.com/article/4691776-guardant-health-inc-gh-q1-2024-earnings-call-transcript

Category:  Health Show Health

Guardant Health to present real-world data supporting

(1 days ago) WEBThe data served as the basis for Guardant Health’s submission of a premarket approval (PMA) application to the FDA, and the full study results have since …

https://www.morningstar.com/news/business-wire/20240516838593/guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week

Category:  Health Show Health

Guardant Health to present real-world data supporting - BioSpace

(2 days ago) WEBGuardant Health unveiled initial results from the ECLIPSE study validating the performance of the Shield test at the 2023 DDW meeting. The data served as the basis …

https://www.biospace.com/article/releases/guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week/

Category:  Health Show Health

GH Stock Earnings: Guardant Health Beats EPS, Beats Revenue for …

(9 days ago) WEBGuardant Health (NASDAQ:GH) just reported results for the first quarter of 2024. Guardant Health reported earnings per share of -46 cents. This was above the …

https://investorplace.com/earning-results/2024/05/gh-stock-earnings-guardant-health-for-q1-of-2024/

Category:  Health Show Health

Filter Type: